Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Cancer, Papillary × pralsetinib × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Thoracic Neoplasms 1 Solid Tumors 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Neoplasms, Nerve Tissue 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Lung Neoplasms 1 Lung Diseases 1 Head and Neck Neoplasms 1 Carcinoma, Bronchogenic 1 Carcinoma 1 Bronchial Diseases 1 Adenocarcinoma 1

Interventions

tremelimumab 1 trametinib 1 gallium Ga 68 dotatate 1 entrectinib 1 durvalumab 1 dabrafenib 1 Surveys and Questionnaires 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡